The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research

por Ketchum, Fred B., Chin, Nathaniel A., Erickson, Claire, Lambrou, Nickolas H., Basche, Kristin, Gleason, Carey E., Clark, Lindsay
Publicado 2023

Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society

por Erickson, Claire M., Clark, Lindsay R., Ketchum, Fred B., Chin, Nathaniel A., Gleason, Carey E., Largent, Emily A.
Publicado 2022

What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer’s Disease Biomarker Research? A Qualitative Vignette Analysis

por Ketchum, Fred B., Erickson, Claire M., Chin, Nathaniel A., Gleason, Carey E., Lambrou, Nickolas H., Benton, Susan Flowers, Clark, Lindsay R.
Publicado 2022

Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing

por Ketchum, Fred B., Chin, Nathaniel A., Grill, Joshua, Gleason, Carey E., Erickson, Claire, Clark, Lindsay R., Paulsen, Jane S., Kind, Amy J.H.
Publicado 2022

Cardiology clinic patient attitudes toward and potential personal utility of genetic testing: Findings from a unique multiracial clinical sample

por Erickson, Claire M., Clark, Lindsay R., Umucu, Emre, Vo, Nhi H., Volgman, Annabelle Santos, Chin, Nathaniel A., Ketchum, Fred B., Jones, Carolyn H., Gleason, Carey E., Aggarwal, Neelum T.
Publicado 2022

Alzheimer's disease biomarkers in Black and non‐Hispanic White cohorts: A contextualized review of the evidence

por Gleason, Carey E., Zuelsdorff, Megan, Gooding, Diane C., Kind, Amy J. H., Johnson, Adrienne L., James, Taryn T., Lambrou, Nickolas H., Wyman, Mary F., Ketchum, Fred B., Gee, Alexander, Johnson, Sterling C., Bendlin, Barbara B., Zetterberg, Henrik
Publicado 2021